Reeve Foundation Paralysis Community

This from Monday's Washington Post: One year after President Obama announced he was lifting his predecessor's controversial restrictions on federal funding for human embryonic stem cell research, some scientists are complaining that so far the new Read More

An article in the recent journal Nature explains a new venture between Big Pharma and academic laboratories to use stem cells to test potential drugs against a variety of diseases. If successful (and success is not necessarily preordained, as the article Read More

This from Nature.com: Adult mouse cells can now be reprogrammed to a stem-cell-like state with the help of a single genetic insertion — rather than the multiple gene insertions required in the past. The advance also enables reprogrammable mice to be Read More

There is a move to start holding companies that are offering unapproved stem cell "therapies" accountable. The Reeve Foundation's Knowledge Manager, Sam Maddox, takes a closer look. Read more.Read Nature.com's blog on the topic.Rob Read More

The Lasker Awards have been announced. Among the winners are John Gurdon of Cambridge University and Shinya Yamanaka of Kyoto University and the University of California, San Francisco. They will share the 2009 Albert Lasker Basic Medical Research Award Read More

The following provides some explanation of the FDA hold on the Geron trial. Geron Corporation (Nasdaq:GERN) today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND. As biologic therapeutics advance in clinical Read More

This was posted earlier today (Tuesday): Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been Read More

"Two teams of Chinese researchers working separately have reprogrammed mature skin cells of mice to an embryonic-like state and used the resulting cells to create live mouse offspring." Read more. Read More